Drawing for NEORX

USPTO serial 78197762

NEORX

Reviewed by CopyMark Law Group

Reg. 2831957Status 710
Filing date
Status date
Registration date
Apr 13, 2004
Examiner
ISAACSON, GINNY
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with NEORX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rochelle D. Alpert

ROCHELLE D ALPERT MORGAN, LEWIS & BOCKIUS, LLPONE MARKET SPEAR ST TWRSAN FRANCISCO, CA 94105UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic pharmaceutical products and reagents, namely biochemical and biological reagents for localizing active agents for use in pharmaceutical and scientific researchSECTION 8 - CANCELLEDJan 6, 2002
005Therapeutic, diagnostic and prophylactic pharmaceutical preparations and reagents for the treatment, diagnosis and prophylaxis of cancerSECTION 8 - CANCELLEDJan 6, 2002
040Contract manufacture of pharmaceuticals, biologics, controlled substances and radioactive substances for othersSECTION 8 - CANCELLEDJan 6, 2002
042Scientific research and development of preparations, agents and biotechnology for the treatment, diagnosis and prophylaxis of cancer; conducting clinical trials; providing scientific information to scientists, physicians and health care providers; the licensing of proprietary intellectual propertySECTION 8 - CANCELLEDJan 6, 2002

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 19, 2010C8..CANCELLED SEC. 8 (6-YR)—
Jun 21, 2006ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 13, 2004R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 20, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 31, 2003NPUBNOTICE OF PUBLICATION—
Nov 24, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 21, 2003GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 14, 2003ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Sep 15, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 29, 2003CFITCASE FILE IN TICRS—
Aug 1, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 1, 2003MAILPAPER RECEIVED—
Jun 5, 2003GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 2, 2003DOCKASSIGNED TO EXAMINER—
May 8, 2003TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 6, 2003TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—

Frequently asked questions

Related guidance